Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

12.61
+0.22001.78%
Pre-market: 12.42-0.1900-1.51%04:00 EDT
Volume:175.77K
Turnover:2.21M
Market Cap:33.01M
PE:- -
High:12.74
Open:12.68
Low:12.40
Close:12.39
52wk High:36.00
52wk Low:9.23
Shares:2.62M
Float Shares:2.62M
Volume Ratio:0.54
T/O Rate:6.71%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo Nordisk (NVO) Faces A Fair Value Debate, Is It Still 55% Undervalued?

Simply Wall St.
·
Aug 07

Novo Nordisk A/S Stock (NVO) Closed Up by 3.11% on Aug 6: What Investors Need To Know

TradingKey
·
Aug 07

Amazon Pharmacy to Offer GLP-1 Weight-Loss Medications to Medicare Part D Patients

Dow Jones
·
Aug 06

Novo Nordisk (0QIU) Gets a Hold from Goldman Sachs

TIPRANKS
·
Aug 06

How Novo Nordisk's CEO Says He is Shifting the Company's Perspective

Dow Jones
·
Aug 06

Novo Nordisk's Conservative Guidance Leaves Room for Further Upgrades

Dow Jones
·
Aug 06

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.6%

TIPRANKS
·
Aug 06

Novo Nordisk (NYSE:NVO) Stock May Be Below Fair Value On ZEUS Trial Fallout

Simply Wall St.
·
Aug 06

European Stocks Stalled Near Records as HSBC and Novo Nordisk Weigh

Deep News
·
Aug 06

Money Quote: Novo Nordisk CEO

Dow Jones
·
Aug 06

How Ozempic Maker Novo Nordisk Blew Its Lead in GLP-1 Weight-Loss Drugs. Can Europe Compete in the High-Stakes Global Economy?

Dow Jones
·
Aug 06

Bank of America CEO Reveals $250 Million Annual Employee Investment in Weight-Loss Medications

Deep News
·
Aug 06

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Aug 06

Novo Nordisk Stock (NVO) Recovers as Earnings Surprise to the Upside

TIPRANKS
·
Aug 05

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Reuters
·
Aug 05

Novo Nordisk Wins Dutch Injunction in Ceban Semaglutide Patent Case

MT Newswires Live
·
Aug 05

Novo Nordisk CEO Remains Open to Bolt-on Acquisitions, but Rules Out Transformative Deals

Dow Jones
·
Aug 05

Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth

Bloomberg
·
Aug 05

UBS Keeps Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
Aug 05

Novo-Nordisk CEO Defends Wegovy Oral Pill Amid Pricing Pressure, Shares Slide on Sales Concern

Deep News
·
Aug 05